{"disease":{"id":"allosensitization","name":"allosensitization"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03689075","title":"Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Imperial College Healthcare NHS Trust","has_results":false},{"nct_id":"NCT04204980","title":"Desensitization in Kidney Allograft Using Daratumumab","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04610320","title":"Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Ronald Witteles","has_results":false},{"nct_id":"NCT05862766","title":"Isatuximab in Lung Transplant Recipients","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT04088903","title":"Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Ronald Witteles","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}